undamentalytics Newsletter
Sign in

Talphera, Inc. income statement

In fiscal 2025, Talphera, Inc. reported revenue of $28,000, operating income of −$13.5m (a -48157.1% margin) and net income of −$14.3m. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue1230519178225301000
Cost of revenue—————121147643————
Gross profit—————5−3−2−5−1−1−3————
Research and development142526252221191354436767
Selling, general and administrative——————17214536311712978
General and administrative7710181416——————————
Operating income——−7−38−20−32−39−36−54−41−36−25−17−15−13−15
Interest expense22233332332100——
Income before tax−19−30−7−38−24−43−52−47−53−40−3559−10———
Income tax00001−0−100000000—
Net income−20−33−23−33−24−43−52−47−53−40−3548−18−13−14−15
Diluted EPS−$11.60−$0.76−$0.29−$0.46−$0.30−$0.47−$11.00−$0.41−$0.34−$0.23−$2.93$2.86−$1.29———
Diluted shares (average)2m2m4m4m4m5m5m6m8m9m12m15m14m26m42m—
EBITDA——−6−37−18−30−37−35−53−39−34−24−17−15——

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: PRFX vs TLPHAKAN vs TLPHSCNX vs TLPH

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from Talphera, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Talphera, Inc.